Kolexia
Berger Franck Santé publique
Berger Franck
Santé publique
Hopital Instruction des Armees Laveran
Marseille, France
67 Activités
164 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Cellules tumorales circulantes Paludisme Tumeurs du sein triple-négatives Carcinome canalaire du sein Coqueluche Métastase tumorale Rougeole Paludisme à Plasmodium falciparum

Collaborateurs

Voir plus
Pierga Jean-Yves
Pierga Jean-Yves
Clcc Institut Curie, Paris, France
Bidard Francois-Clement
Bidard Francois-Clement
Clcc Institut Curie, Paris, France
Michel Remy
Michel Remy
A.s.t Grand Lyon, Villeurbanne, France
Meynard Jean-Baptiste
Meynard Jean-Baptiste
Service de santé des armées françaises, Paris, France

Industries

Voir plus
Hemotech
1 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Concurrent Olaparib with Radiotherapy in Patients with Triple Negative Breast Cancer: Final Results of the RADIOPARP Phase 1 Trial
ASTRO Annual 2022 Meeting   01 novembre 2022
One-Year Toxicity Report of the RADIOPARP Phase I Trial Evaluating Olaparib With Radiotherapy for Triple Negative Breast Cancer
2021 Proceedings of the ASTRO 63rd Annual Meeting   01 novembre 2021
Role of Anopheles stephensi Mosquitoes in Malaria Outbreak, Djibouti, 2019.
Emerging infectious diseases   05 juillet 2021
RADIOPARP: A Phase I of Olaparib with Radiation Therapy (RT) in Patients with Inflammatory, Loco-regionally Advanced or Metastatic TNBC (Triple Negative Breast Cancer) or Patient with Operated TNBC with Residual Disease
Proceedings of the American Society for Radiation Oncology 2020   01 novembre 2020
304P ESR1 mutations and outcomes in BRCA1/2 or PALB2 germline mutation carriers receiving first line aromatase inhibitor + palbociclib (AI+P) for metastatic breast cancer (MBC) in the PADA-1 trial
Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020   01 septembre 2020
Monitoring of returnees from Ebola-affected areas: lessons learned based on the experience of French armed forces deployed in Guinea, 2015.
Journal of public health (Oxford, England)   07 novembre 2019
Use of MALDI-TOF MS for the Identification of Chad Mosquitoes and the Origin of Their Blood Meal.
The American journal of tropical medicine and hygiene   17 octobre 2019
Nanostructured tin oxide materials for the sub-ppm detection of indoor formaldehyde pollution.
Talanta   01 octobre 2019
Emergence of ESR1 mutation in cell-free DNA during first line aromatase inhibitor and palbociclib: An exploratory analysis of the PADA-1 trial
Abstract Book of the 44th ESMO Congress (ESMO 2019) 27 September – 1 October 2019, Barcelona, Spain   01 octobre 2019
V726 SIOP19-0642 Molecular and Immunological Characterisation of High Risk Cancer at Diagnosis, During Treatment and Follow-Up in Children, Adolescents and Young Adults: The French Micchado Study
Abstracts from the 51st Congress of the International Society of Paediatric Oncology (SIOP) Lyon, France, October 23–26, 2019   30 septembre 2019